The continued development of enabling molecular technologies that can be employed to better understand viral replication and the action of currently available therapeutic agents promises to lead to the development of the next generation of drugs with improved therapeutic utility against human immunodeficiency virus (HIV) and hepatitis C virus (HCV). New therapeutic approaches have been developed for treating HIV and HCV infections, but key technical and therapeutic challenges must be addressed to further advance treatment options in each of these areas.
机构:
MedStar Washington Hosp Ctr, Sect Pulm & Crit Care Med AFS, Washington, DC 20010 USAMedStar Washington Hosp Ctr, Sect Pulm & Crit Care Med AFS, Washington, DC 20010 USA
Shorr, Andrew F.
Zilberberg, Marya D.
论文数: 0引用数: 0
h-index: 0
机构:
Evimed Res, Goshen, MA USAMedStar Washington Hosp Ctr, Sect Pulm & Crit Care Med AFS, Washington, DC 20010 USA